Disinfectant caps lower CLABSI cases and costs

Using disinfectant caps on intravenous needleless connectors led to a 40 percent drop in central line–associated bloodstream infections, according to a recent study published in the American Journal of Infection Control.

Advertisement

For the study, a new intervention of using a luer-lock disinfectant cap with 70 percent alcohol was implemented in all IV needleless connectors for patients with peripheral and central lines in a trauma center.

The new disinfectant caps, along with the use of a standard central line bundle, led to a roughly 40 percent decrease in CLABSIs.

In addition to lowering infection rates, the use of the disinfectant caps was associated with an estimated savings of nearly $300,000 a year in the hospital studied.

 

 

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.